OVA (257-264), amide is the SIINFEKL epitope presented in C-terminally amidated form for stability and conformational tuning. Its sequence supports high-affinity MHC binding while allowing investigation of terminal-charge effects. Researchers employ it to compare epitope behavior with free-acid counterparts. The peptide aids refined modeling of OVA peptide presentation.
CAT No: O05012
1. Autoinhibition and phosphorylation-induced activation of phospholipase C-γ isozymes
2. Emu oil in combination with other active ingredients for treating skin imperfections
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.